This brief addresses the model-based control of the air path of diesel engines in terms of an optimal control problem with input constraints which can be solved using model predictive algorithms. A multilinear model identified from data and a switched controller design are used to cope with the nonlinearity of the engine. Experimental results on a production engine confirm that the proposed control method strongly improves the dynamics of the air path and enormously reduces the parameterization work if compared with the conventional approach. To obtain improvements in emissions as well, the new controller approach cannot simply be plugged in at the site of the conventional one, but new set points must be determined. After such a redesign, improvements of 50% in terms of nitrogen oxides and of 10% in terms of particulate matter have been recorded without a net consumption increase, the main price being the increased activity of the turbocharger vane and especially of the exhaust gas recirculation valve
23 February 2017 in IEEE Transactions on Control Systems Technology
This paper proposes a stochastic model predictive control (MPC) approach to optimize the fuel consumption in a vehicle following context. The practical solution of that problem requires solving a constrained moving horizon optimal control problem using a short-term prediction of the preceding vehicle's velocity. In a deterministic framework, the prediction errors lead to constraint violations and to harsh control reactions. Instead, the suggested method considers errors, and limits the probability of a constraint violation. A conditional linear Gauss model is developed and trained with real measurements to estimate the probability distribution of the future velocity of the preceding vehicle. The prediction model is used to evaluate two different stochastic MPC approaches. On the one hand, an MPC with individual chance constraints is applied. On the other hand, samples are drawn from the conditional Gaussian model and used for a scenario-based optimization approach. Finally, both developed control strategies are evaluated and compared against a standard deterministic MPC. The evaluation of the controllers shows a significant reduction of the fuel consumption compared with standard adaptive cruise control algorithms.
19 June 2019 in Journal of Diabetes Science and Technology
High-quality performance of medical devices for glucose monitoring is important for a safe and efficient usage of this diagnostic option by patients with diabetes. The mean absolute relative difference (MARD) parameter is used most often to characterize the measurement performance of systems for continuous glucose monitoring (CGM). Calculation of this parameter is relatively easy and comparison of the MARD numbers between different CGM systems appears to be straightforward on the first glance. However, a closer look reveals that a number of complex aspects make interpretation of the MARD numbers provided by the manufacturer for their CGM systems difficult. In this review, these aspects are discussed and considerations are made for a systematic and appropriate evaluation of the MARD in clinical trials. The MARD should not be used as the sole parameter to characterize CGM systems, especially when it comes to nonadjunctive usage of such systems.
4 August 2015 in Journal of Diabetes Science and Technology
Background: Continuous glucose monitoring (CGM) is a powerful tool to support the optimization of glucose control of patients with diabetes. However, CGM systems measure glucose in interstitial fluid but not in blood. Rapid changes in one compartment are not accompanied by similar changes in the other, but follow with some delay. Such time delays hamper detection of, for example, hypoglycemic events. Our aim is to discuss the causes and extent of time delays and approaches to compensate for these. Methods: CGM data were obtained in a clinical study with 37 patients with a prototype glucose sensor. The study was divided into 5 phases over 2 years. In all, 8 patients participated in 2 phases separated by 8 months. A total number of 108 CGM data sets including raw signals were used for data analysis and were processed by statistical methods to obtain estimates of the time delay. Results: Overall mean (SD) time delay of the raw signals with respect to blood glucose was 9.5 (3.7) min, median was 9 min (interquartile range 4 min). Analysis of time delays observed in the same patients separated by 8 months suggests a patient dependent delay. No significant correlation was observed between delay and anamnestic or anthropometric data. The use of a prediction algorithm reduced the delay by 4 minutes on average. Conclusions: Prediction algorithms should be used to provide real-time CGM readings more consistent with simultaneous measurements by SMBG. Patient specificity may play an important role in improving prediction quality.
Reduction of fuel consumption is one of the primary goals of modern automotive engineering. While in the past the focus was on more efficient engine design and control there is an upcoming interest on economic context aware control of the complete vehicle. Technical progress will enable future vehicles to interact with other traffic participants and the surrounding infrastructure, collecting information which allow for reduction of fuel consumption by predictive vehicle control strategies. The principle of Model Predictive Control allows a straightforward integration of e.g. navigation systems, on-board radar sensors, V2V- and V2I-communication whilst regarding constraints and dynamic of the system. This paper presents a Linear Model Predictive Control approach to Cooperative Adaptive Cruise Control, directly minimizing the fuel consumption rather than the acceleration of the vehicle. To this end the nonlinear static fuel consumption map of the internal combustion engine is included into the control design by a piecewise quadratic approximation. Inclusion of a linear spacing policy prevents rear end collisions. Simulation results demonstrate the fuel and road capacity benefits, for a single vehicle and for a string of vehicles, equipped with the proposed control, in comparison to vehicles operated by a non-cooperative adaptive cruise control. Full information on the speed prediction of the predecessor is assumed, hence the purpose of this paper is twofold. On the one hand, best achievable benefits, of the proposed control, due to perfect prediction are demonstrated. On the other hand, the paper studies the behavior of the considered control and the influence of the prediction horizon.
25 September 2016 in Journal of Diabetes Science and Technology
Background: There is a need to assess the accuracy of continuous glucose monitoring (CGM) systems for several uses. Mean absolute relative difference (MARD) is the measure of choice for this. Unfortunately, it is frequently overlooked that MARD values computed with data acquired during clinical studies do not reflect the accuracy of the CGM system only, but are strongly influenced by the design of the study. Thus, published MARD values must be understood not as precise values but as indications with some uncertainty. Data and Methods: Data from a recent clinical trial, Monte Carlo simulations, and assumptions about the error distribution of the reference measurements have been used to determine the confidence region of MARD as a function of the number and the accuracy of the reference measurements. Results: The uncertainty of the computed MARD values can be quantified by a newly introduced MARD reliability index (MRI), which independently mirrors the reliability of the evaluation. Thus MARD conveys information on the accuracy of the CGM system, while MRI conveys information on the uncertainty of the computed MARD values. Conclusions: MARD values from clinical studies should not be used blindly but the reliability of the evaluation should be considered as well. Furthermore, it should not be ignored that MARD does not take into account the key feature of CGM sensors, the frequency of the measurements. Additional metrics, such as precision absolute relative difference (PARD) should be used as well to obtain a better evaluation of the CGM performance for specific uses, for example, for artificial pancreas.